S&P Futures
4,137.50-18.00(-0.43%)Dow Futures
33,807.00-151.00(-0.44%)Nasdaq Futures
13,840.00-57.25(-0.41%)
iRhythm Technologies, Inc. (IRTC)
90.96 +1.38 (1.54%)
Pre-Market: 4:38AM EDT
Chart Events
Performance Outlook
| Previous Close | 90.94 |
| Open | 90.25 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's Range | 88.77 - 92.11 |
| 52 Week Range | 77.43 - 286.19 |
| Volume | 511,909 |
| Avg. Volume | 795,367 |
| Market Cap | 2.612B |
| Beta (5Y Monthly) | 1.66 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
- Simply Wall St.
iRhythm Technologies, Inc. (NASDAQ:IRTC) Analysts Just Cut Their EPS Forecasts Substantially
The analysts covering iRhythm Technologies, Inc. ( NASDAQ:IRTC ) delivered a dose of negativity to shareholders today...
- Motley Fool
Why iRhythm Technologies Stock Is Crashing Today
Novitas' new Medicare reimbursement rates translate to significantly lower revenue for the cardiac care company.
- TheStreet.com
iRhythm Plunges as Novitas Updates Medicare Reimbursement Rate
Shares of ambulatory electrocardiogram monitoring device maker iRhythm Technologies fell sharply after Medicare contractor Novitas updated reimbursement rates for coding related to iRhythm's ZioXT service. While the new rates represent an increase from previous rates, iRhythm says it believes they don't appropriately reflect the clinical and economic value that long-term continuous electrocardiogram monitoring offers patients. The company says that due to the cost of providing the service relative to the updated rates published by Novitas, it won't be able to provide its Zio XT service to the Medicare fee-for-service segment if rates remain the same.
